News

GoldenTree Asset Management Successfully Closes $599 Million CLO

GoldenTree Asset Management Successfully Closes $599 Million CLO

GoldenTree Asset Management Completes $599 Million CLO

GoldenTree Asset Management LP recently announced the successful closing of a substantial $599 million collateralized loan obligation (CLO), designated as GLM US CLO 22. This milestone exemplifies the effectiveness and strength of GoldenTree's GLM strategy in managing collateralized loan obligations since its inception.

Overview of GLM Strategy

The GLM strategy was launched with the aim of adhering to applicable Risk Retention regulations. Although legal developments have altered the landscape surrounding US risk retention rules, the GLM CLOs continue to align with the regulatory frameworks of the European Union and the United Kingdom. This commitment to compliance enhances investor confidence and demonstrates GoldenTree's proactive approach to navigating a complex regulatory environment.

Details of GLM US CLO 22

GLM US CLO 22 is initially backed by a comprehensive portfolio of primarily senior secured loans amounting to $598 million. This CLO includes a strategic five-year reinvestment period and a two-year non-call period, which facilitates prudent financial management. The arrangement was effectively executed by BNP Paribas Securities Corp., showing the importance of strong partnerships in the CLO market.

Financial Highlights

In terms of financial structure, GLM US CLO 22 issued $384 million of AAA rated senior notes, boasting a competitive coupon rate of S+1.33%. Additionally, the overall weighted average coupon stands at S+1.76%, illustrating the CLO's favorable financial posture within the lending market. This diverse mix of notes contributes to the robustness of the investment's return potential.

The Track Record of GoldenTree Asset Management

Since its founding in 2000, GoldenTree has made a significant impact within the asset management arena, having issued over $25 billion across CLOs and collateralized bond obligations (CBOs). Currently, over $13 billion of these securities remains outstanding, underscoring the firm's ongoing relevance and influence in the credit markets. The organization is staffed by a team of nearly 100 skilled professionals who bring an average of 15 years of experience across more than 30 industries.

GoldenTree’s Investment Philosophy

GoldenTree specializes in a wide range of investment opportunities spanning the credit landscape, including high-yield bonds, leveraged loans, private credit, distressed debt, and structured credit. The firm manages approximately $56 billion for a diverse range of institutional investors, including public and corporate pensions, endowments, foundations, and insurance companies.

Global Presence and Expertise

With over 310 employees operating in various global offices, including major cities such as New York, London, and Tokyo, GoldenTree is well-positioned to capitalize on emerging trends and opportunities within the market. Its extensive expertise facilitates a well-rounded approach to both risk and return in the ever-evolving financial landscape.

Frequently Asked Questions

What is GLM US CLO 22?

GLM US CLO 22 is a $599 million collateralized loan obligation managed by GoldenTree Asset Management, focusing on a diverse portfolio of senior secured loans.

What distinguishes the GLM strategy?

The GLM strategy is recognized for its commitment to regulatory compliance and risk retention, primarily aligning with EU and UK regulations following changes in US law.

Who arranged the CLO and what is its structure?

BNP Paribas Securities Corp. served as the sole lead arranger, and the structure includes a mix of AAA rated senior notes with a competitive weighted average coupon.

How does GoldenTree manage risk?

GoldenTree employs a diverse investment philosophy, backed by extensive expertise within its experienced team, which allows it to carefully assess and manage risk across different credit sectors.

Where does GoldenTree operate?

GoldenTree has a global presence with offices in multiple cities, including New York, London, and Tokyo, allowing for a broad understanding of various market dynamics.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 4

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading

Top 5 Most Recently Viewed Articles

NotHappening Launches Unique Luxury Streetwear in NYC

Updated Category News Views 456

A Bold Fashion Statement: NotHappening Launches Today, a remarkable fashion phenomenon has emerged, capturing the imagination of enthusiasts and critics alike. NotHappening, a daring new brand, has made its grand entrance into the world of luxury streetwear, and it's more than just a fashion label; it's a commentary on contemporary culture and the pervasive influence of...

Continue Reading
Hormone Evaluation Steps: Insights from Annette Asper

Updated Category News Views 27

Navigating Hormone Evaluations with Clarity In the labyrinth of healthcare, figuring out what's crucial for your well-being can be a tangled mess. Today's focus is unraveling the often-overlooked world of hormone evaluations. It's not just about popping pills based on hunches—it's about getting a well-rounded picture of your health. Annette Asper from Rewritten Klinik...

Continue Reading
Radix Launches Innovations in Asset Integrity at Amsterdam Event

Updated Category News Views 101

Radix Showcases Innovations in Digital Twin Technology Radix is all set to unveil its groundbreaking innovations in asset integrity and energy transition at the renowned Future Digital Twin & Generative AI Conference. Hosted at the Energy Transition Campus in Amsterdam, this event is a gathering of industry experts and technology leaders aimed at tackling significant...

Continue Reading
Genmab Gets FDA Approval for Epcoritamab Combo for Lymphoma

Updated Category News Views 182

Genmab's Epcoritamab Combination Therapy Approved Company Announcement Genmab A/S (NASDAQ: GMAB) has achieved an important milestone with the FDA's approval of Epcoritamab, marketed as EPKINLY®, combined with rituximab and lenalidomide, a trio set to offer hope to adults suffering from relapsed or refractory follicular lymphoma (R/R FL). Pivotal Phase 3 Study Results The...

Continue Reading
EchoStar Corporation Posts Strong Growth in Q2 Financials

Updated Category News Views 171

EchoStar Corporation Financial Results Overview EchoStar Corporation (NASDAQ: SATS) has released its impressive financial results for the recently concluded quarter. The results indicate a robust performance, emphasizing growth across several key business areas. The company has focused on enhancing its operational efficiencies while ensuring that customer experiences are...

Continue Reading